Sargent Investment Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.08M | Sell |
25,599
-372
| -1% | -$42.9K | 0.41% | 56 |
|
|
2025
Q4 | $2.73M | Buy |
25,971
+153
| +0.6% | +$14.4K | 0.34% | 57 |
|
|
2025
Q3 | $2.17M | Buy |
25,818
+2,280
| +10% | +$188K | 0.31% | 65 |
|
|
2025
Q2 | $1.87M | Buy |
23,538
+3,522
| +18% | +$280K | 0.25% | 71 |
|
|
2025
Q1 | $1.8M | Buy |
20,016
+1,160
| +6% | +$108K | 0.29% | 64 |
|
|
2024
Q4 | $1.9M | Buy |
18,856
+6,386
| +51% | +$658K | 0.31% | 66 |
|
|
2024
Q3 | $1.42M | Sell |
12,470
-1,615
| -11% | -$192K | 0.25% | 68 |
|
|
2024
Q2 | $1.74M | Buy |
14,085
+1,328
| +10% | +$171K | 0.36% | 62 |
|
|
2024
Q1 | $1.68M | Sell |
12,757
-1,606
| -11% | -$198K | 0.37% | 59 |
|
|
2023
Q4 | $1.57M | Buy |
14,363
+73
| +0.5% | +$7.58K | 0.34% | 60 |
|
|
2023
Q3 | $1.47M | Buy |
14,290
+2,272
| +19% | +$245K | 0.35% | 60 |
|
|
2023
Q2 | $1.39M | Buy |
12,018
+590
| +5% | +$67K | 0.34% | 63 |
|
|
2023
Q1 | $1.24M | Buy |
11,428
+184
| +2% | +$19.9K | 0.33% | 67 |
|
|
2022
Q4 | $1.25M | Buy |
11,244
+1,496
| +15% | +$153K | 0.39% | 66 |
|
|
2022
Q3 | $852K | Buy |
9,748
+250
| +3% | +$22.3K | 0.27% | 76 |
|
|
2022
Q2 | $866K | Hold |
9,498
| – | – | 0.27% | 73 |
|
|
2022
Q1 | $779K | Hold |
9,498
| – | – | 0.2% | 92 |
|
|
2021
Q4 | $728K | Sell |
9,498
-290
| -3% | -$23.1K | 0.17% | 95 |
|
|
2021
Q3 | $735K | Buy |
9,788
+60
| +0.6% | +$4.56K | 0.18% | 96 |
|
|
2021
Q2 | $757K | Sell |
9,728
-944
| -9% | -$70.2K | 0.18% | 93 |
|
|
2021
Q1 | $785K | Buy |
10,672
+1,913
| +22% | +$141K | 0.21% | 83 |
|
|
2020
Q4 | $684K | Buy |
8,759
+703
| +9% | +$53.8K | 0.22% | 86 |
|
|
2020
Q3 | $638K | Sell |
8,056
-18
| -0.2% | -$1.41K | 0.23% | 80 |
|
|
2020
Q2 | $602K | Hold |
8,074
| – | – | 0.23% | 79 |
|
|
2020
Q1 | $593K | Buy |
8,074
+103
| +1% | +$8.1K | 0.27% | 67 |
|
|
2019
Q4 | $692K | Buy |
7,971
+661
| +9% | +$54.3K | 0.25% | 77 |
|
|
2019
Q3 | $587K | Sell |
7,310
-13
| -0.2% | -$1.04K | 0.26% | 79 |
|
|
2019
Q2 | $586K | Sell |
7,323
-996
| -12% | -$76.3K | 0.27% | 76 |
|
|
2019
Q1 | $660K | Buy |
8,319
+1,017
| +14% | +$76.1K | 0.32% | 70 |
|
|
2018
Q4 | $532K | Buy |
+7,302
| New | +$515K | 0.33% | 63 |
|
Other funds holding MRK
VCM
VPM
Sargent Investment Group's MRK Position: Q1 2026 in Review
Sargent Investment Group reduced its Merck (MRK) stake by 1.4% in Q1 2026, selling an estimated $42.9K and leaving 25,599 shares worth $3.08M. The position accounts for 0.41% of the portfolio, ranked #56.
Sargent Investment Group first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Sargent Investment Group held 25,599 shares of Merck worth $3.08M as of Q1 2026.
- Sargent Investment Group sold 372 Merck shares in Q1 2026, an estimated $42.9K.
- Merck made up 0.41% of Sargent Investment Group's portfolio in Q1 2026, its #56 holding.
- Sargent Investment Group first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.